CSL Ltd. (CMXHF)
128.00
+4.78
(+3.88%)
USD |
OTCM |
Sep 17, 16:00
CSL Market Cap : 61.30B for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 61.30B |
| September 16, 2026 | 59.01B |
| September 15, 2026 | 58.43B |
| September 14, 2026 | 58.43B |
| September 11, 2026 | 60.43B |
| September 10, 2026 | 60.43B |
| September 09, 2026 | 60.43B |
| September 08, 2026 | 60.43B |
| September 04, 2026 | 60.72B |
| September 03, 2026 | 57.68B |
| September 02, 2026 | 57.47B |
| September 01, 2026 | 57.47B |
| August 31, 2026 | 57.47B |
| August 28, 2026 | 57.47B |
| August 27, 2026 | 57.47B |
| August 26, 2026 | 57.47B |
| August 25, 2026 | 57.47B |
| August 24, 2026 | 57.47B |
| August 21, 2026 | 57.47B |
| August 20, 2026 | 57.47B |
| August 19, 2026 | 56.84B |
| August 18, 2026 | 53.30B |
| August 17, 2026 | 46.95B |
| August 14, 2026 | 46.95B |
| August 13, 2026 | 46.95B |
| Date | Value |
|---|---|
| August 12, 2026 | 47.26B |
| August 11, 2026 | 46.38B |
| August 10, 2026 | 45.16B |
| August 07, 2026 | 44.17B |
| August 06, 2026 | 45.03B |
| August 05, 2026 | 43.53B |
| August 04, 2026 | 43.53B |
| August 03, 2026 | 42.32B |
| July 31, 2026 | 42.36B |
| July 30, 2026 | 42.88B |
| July 29, 2026 | 42.88B |
| July 28, 2026 | 38.56B |
| July 27, 2026 | 38.56B |
| July 24, 2026 | 39.52B |
| July 23, 2026 | 39.52B |
| July 22, 2026 | 39.52B |
| July 21, 2026 | 40.43B |
| July 20, 2026 | 41.22B |
| July 17, 2026 | 41.22B |
| July 16, 2026 | 41.22B |
| July 15, 2026 | 41.65B |
| July 14, 2026 | 41.65B |
| July 13, 2026 | 41.65B |
| July 10, 2026 | 41.65B |
| July 09, 2026 | 41.65B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immutep Ltd. | 46.25M |
| Ceryvyn Therapeutics Ltd. | 3.967M |
| Propanc Biopharma, Inc. | 0.5669M |
| Mesoblast Ltd. | 1.928B |
| Actinogen Medical Ltd. | 115.59M |
Market Cap Related Metrics
| PS Ratio | 3.934 |
| Price to Free Cash Flow | 27.63 |
| Price | 128.00 |
| Earnings Yield | -4.22% |
| Operating PE Ratio | 15.45 |
| Normalized PE Ratio | 21.59 |